Retatrutide 60mg

Retatrutide – 60mg

Retatrutide is a next-generation triple receptor agonist targeting GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors simultaneously. As a triple incretin mimetic, it represents one of the most advanced research compounds in the field of metabolic biology and energy homeostasis.

Product Specifications

• Peptide: Retatrutide
• Quantity: 60mg per vial
• Purity: ≥99% (HPLC verified)
• Form: Lyophilised powder
• Storage: Store at -20°C. Protect from light and moisture.

Research Applications

Retatrutide has attracted considerable scientific interest due to its triagonist mechanism of action. Researchers are investigating its effects on metabolic rate, adipose tissue reduction, glycaemic control, and hepatic lipid metabolism. Its simultaneous engagement of three incretin-related receptors makes it a particularly valuable tool for studying the interplay between GIP, GLP-1, and glucagon signalling pathways.

For research use only. Not for human consumption. This product is intended solely for use in laboratory and scientific research settings by qualified professionals.